Artivion Company Insiders
AORT Stock | USD 29.05 0.39 1.36% |
Artivion's insiders are aggressively selling. The analysis of insiders' sentiment of trading Artivion stock suggests that vertually all insiders are panicking at this time. Artivion employs about 1.5 K people. The company is managed by 27 executives with a total tenure of roughly 170 years, averaging almost 6.0 years of service per executive, having 55.56 employees per reported executive.
Artivion's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-10-01 | Amy Horton | Disposed 12430 @ 26.18 | View | ||
2024-08-26 | Jean F Holloway | Disposed 3167 @ 26.55 | View | ||
2024-08-16 | Matthew A Getz | Disposed 9420 @ 25.31 | View | ||
2024-08-15 | Jean F Holloway | Disposed 2383 @ 25.76 | View | ||
2024-08-13 | Anthony B Semedo | Disposed 9709 @ 24.99 | View | ||
2024-05-09 | Jean F Holloway | Disposed 979 @ 23.79 | View | ||
2024-03-20 | Marshall S Stanton | Disposed 2183 @ 20.39 | View | ||
2024-03-15 | Andrew M Green | Disposed 1462 @ 20 | View | ||
2024-03-12 | Matthew A Getz | Disposed 5000 @ 19.94 | View | ||
2024-03-05 | John E Davis | Disposed 2022 @ 18.72 | View | ||
2024-02-27 | Amy Horton | Disposed 325 @ 19.83 | View | ||
2024-02-26 | Rochelle L Maney | Disposed 2315 @ 20.27 | View | ||
2024-02-20 | Amy Horton | Disposed 1695 @ 18.86 | View |
Monitoring Artivion's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Artivion |
Artivion's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Artivion's future performance. Based on our forecasts, it is anticipated that Artivion will maintain a workforce of slightly above 1500 employees by December 2024.Artivion's latest congressional trading
Congressional trading in companies like Artivion, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Artivion by those in governmental positions are based on the same information available to the general public.
2023-11-20 | Senator Tina Smith | Acquired $50K to $100K | Verify | ||
2023-11-19 | Senator Tina Smith | Acquired $50K to $100K | Verify | ||
2022-10-17 | Senator Tina Smith | Acquired $50K to $100K | Verify | ||
2022-10-16 | Senator Tina Smith | Acquired $50K to $100K | Verify |
Artivion Management Team Effectiveness
The company has return on total asset (ROA) of 0.0229 % which means that it generated a profit of $0.0229 on every $100 spent on assets. This is way below average. Artivion's management efficiency ratios could be used to measure how well Artivion manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.08 in 2024. Return On Capital Employed is likely to drop to 0.01 in 2024. At this time, Artivion's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 832 M in 2024, whereas Non Current Liabilities Other is likely to drop slightly above 43.7 M in 2024.Common Stock Shares Outstanding is likely to drop to about 27.7 M in 2024. Net Loss is likely to gain to about (16.4 M) in 2024
Artivion Workforce Comparison
Artivion is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 250,900. Artivion maintains roughly 1,500 in number of employees contributing less than 1% to equities under Health Care industry.
Artivion Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Artivion insiders, such as employees or executives, is commonly permitted as long as it does not rely on Artivion's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Artivion insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-12-01 | 0.5 | 1 | 2 | 12,430 | 24,860 |
2024-06-01 | 4.0 | 8 | 2 | 50,312 | 2,229 |
2024-03-01 | 0.618 | 55 | 89 | 764,667 | 388,716 |
2023-12-01 | 0.8 | 4 | 5 | 170,285 | 32,645 |
2023-06-01 | 2.0 | 10 | 5 | 94,288 | 22,583 |
2023-03-01 | 0.5645 | 35 | 62 | 338,333 | 309,500 |
2022-12-01 | 5.75 | 23 | 4 | 1,025,639 | 5,440 |
2022-03-01 | 0.8704 | 47 | 54 | 613,047 | 185,243 |
2021-12-01 | 0.6 | 3 | 5 | 20,592 | 4,214 |
2021-09-01 | 0.25 | 1 | 4 | 3,645 | 12,690 |
2021-06-01 | 1.0 | 22 | 22 | 167,501 | 198,931 |
2021-03-01 | 0.7778 | 35 | 45 | 414,271 | 88,226 |
2020-12-01 | 0.5833 | 7 | 12 | 42,437 | 77,205 |
2020-09-01 | 3.0 | 6 | 2 | 35,359 | 0.00 |
2020-06-01 | 10.3333 | 31 | 3 | 79,811 | 4,844 |
2020-03-01 | 1.025 | 41 | 40 | 359,712 | 80,447 |
2019-12-01 | 1.1429 | 8 | 7 | 32,201 | 43,687 |
2019-09-01 | 1.5 | 3 | 2 | 1,201 | 0.00 |
2019-06-01 | 0.8667 | 13 | 15 | 72,895 | 138,080 |
2019-03-01 | 0.75 | 33 | 44 | 295,834 | 105,565 |
2018-09-01 | 0.375 | 18 | 48 | 346,078 | 1,162,336 |
2018-06-01 | 0.3684 | 14 | 38 | 61,624 | 107,938 |
2018-03-01 | 1.1333 | 34 | 30 | 377,988 | 105,392 |
2017-12-01 | 0.375 | 6 | 16 | 84,721 | 167,554 |
2017-09-01 | 0.1667 | 1 | 6 | 4,367 | 135,763 |
2017-06-01 | 2.2 | 11 | 5 | 58,241 | 38,549 |
2017-03-01 | 0.6667 | 18 | 27 | 247,849 | 109,766 |
2016-12-01 | 0.3333 | 2 | 6 | 3,000 | 9,000 |
2016-09-01 | 0.4091 | 9 | 22 | 65,789 | 115,990 |
2016-06-01 | 2.0 | 8 | 4 | 62,343 | 17,205 |
2016-03-01 | 1.0606 | 35 | 33 | 617,573 | 103,463 |
2015-12-01 | 0.6667 | 6 | 9 | 21,800 | 34,300 |
2015-09-01 | 3.75 | 15 | 4 | 164,830 | 13,359 |
2015-06-01 | 0.5 | 2 | 4 | 14,000 | 102,335 |
2015-03-01 | 0.9118 | 31 | 34 | 551,415 | 221,893 |
2014-12-01 | 0.6667 | 10 | 15 | 74,844 | 143,995 |
2014-09-01 | 0.9524 | 20 | 21 | 1,436,000 | 152,332 |
2014-06-01 | 0.1 | 1 | 10 | 5,000 | 63,845 |
2014-03-01 | 1.12 | 28 | 25 | 408,065 | 104,331 |
2013-12-01 | 0.3529 | 12 | 34 | 193,000 | 478,465 |
2013-09-01 | 0.1667 | 1 | 6 | 7,500 | 27,475 |
2013-06-01 | 1.8 | 9 | 5 | 85,000 | 11,250 |
2013-03-01 | 1.6875 | 27 | 16 | 404,788 | 60,594 |
2012-09-01 | 0.5 | 1 | 2 | 5,000 | 8,000 |
2012-06-01 | 4.0 | 12 | 3 | 122,100 | 13,000 |
2012-03-01 | 1.2857 | 18 | 14 | 273,513 | 108,848 |
2011-12-01 | 0.7143 | 5 | 7 | 4,000 | 30,433 |
2011-09-01 | 0.5333 | 8 | 15 | 152,509 | 263,357 |
2011-06-01 | 0.75 | 6 | 8 | 60,000 | 62,886 |
2011-03-01 | 2.0 | 10 | 5 | 510,000 | 11,810 |
2010-03-01 | 2.0 | 10 | 5 | 270,000 | 21,315 |
2009-09-01 | 0.4545 | 5 | 11 | 44,800 | 84,412 |
2009-06-01 | 1.0 | 5 | 5 | 146,500 | 128,500 |
2009-03-01 | 8.0 | 8 | 1 | 246,250 | 30,000 |
2008-12-01 | 0.3333 | 1 | 3 | 6,000 | 35,400 |
2008-09-01 | 0.0673 | 7 | 104 | 142,750 | 358,264 |
2008-06-01 | 0.125 | 12 | 96 | 117,665 | 170,915 |
2008-03-01 | 0.3158 | 12 | 38 | 201,444 | 48,108 |
2007-12-01 | 0.6 | 3 | 5 | 18,086 | 24,571 |
2007-09-01 | 0.1429 | 4 | 28 | 147,300 | 169,300 |
2007-06-01 | 0.1121 | 12 | 107 | 552,150 | 439,415 |
2007-03-01 | 0.0918 | 9 | 98 | 191,449 | 28,600 |
2006-09-01 | 0.1429 | 9 | 63 | 211,095 | 179,095 |
2006-06-01 | 1.0 | 7 | 7 | 310,000 | 25,000 |
2006-03-01 | 0.9 | 9 | 10 | 312,000 | 189,184 |
2005-09-01 | 0.3333 | 1 | 3 | 26,819 | 46,819 |
2004-12-01 | 0.7143 | 5 | 7 | 241,364 | 218,164 |
2004-09-01 | 0.4286 | 3 | 7 | 26,000 | 34,190 |
2004-06-01 | 9.0 | 9 | 1 | 105,000 | 12,500 |
2003-12-01 | 0.1429 | 1 | 7 | 25,070 | 31,870 |
2003-09-01 | 0.5 | 1 | 2 | 50,000 | 11,850 |
2003-06-01 | 3.5 | 7 | 2 | 29,467 | 12,967 |
Artivion Notable Stakeholders
An Artivion stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Artivion often face trade-offs trying to please all of them. Artivion's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Artivion's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
James Mackin | Chairman of the Board, President, Chief Executive Officer, Director | Profile | |
D Lee | Chief Financial Officer, Chief Operating Officer, Executive Vice President | Profile | |
Lance CPA | Executive CFO | Profile | |
Jeffrey Burbank | Lead Independent Director | Profile | |
Jean Esq | General VP | Profile | |
CPA CPA | VP Officer | Profile | |
Amy CPA | VP Officer | Profile | |
Daniel Bevevino | Independent Director | Profile | |
Jean Holloway | Senior Vice President Chief Compliance Officer, General Counsel, Secretary | Profile | |
Jon Salveson | Independent Director | Profile | |
Andrew Green | Vice President - Regulatory Affairs | Profile | |
Thomas Ackerman | Independent Director | Profile | |
Rochelle Maney | Vice President - Global Quality Assurance | Profile | |
Scott Capps | Vice President - Clinical Research | Profile | |
Marna Borgstrom | Independent Director | Profile | |
Matthew Getz | Vice President - Human Resources | Profile | |
James Bullock | Independent Director | Profile | |
Anthony Semedo | Independent Director | Profile | |
Dennis Maier | Vice President - Operations | Profile | |
Joshua Wells | Sr Devel | Profile | |
Marshall Stanton | Senior Vice President Clinical Research and Chief Medical Officer | Profile | |
Marshall MD | Senior Officer | Profile | |
Robert Thomson | Vice Development | Profile | |
Florian Tyrs | Vice Operations | Profile | |
F Barthold | Vice President - Research and Development | Profile | |
Amy Horton | Chief Accounting Officer, Vice President | Profile | |
John Davis | Senior Vice President - Global Sales and Marketing | Profile |
About Artivion Management Performance
The success or failure of an entity such as Artivion often depends on how effective the management is. Artivion management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Artivion management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Artivion management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.08) | (0.08) | |
Return On Capital Employed | 0.01 | 0.01 | |
Return On Assets | (0.04) | (0.04) | |
Return On Equity | (0.11) | (0.10) |
Please note, the imprecision that can be found in Artivion's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Artivion. Check Artivion's Beneish M Score to see the likelihood of Artivion's management manipulating its earnings.
Artivion Workforce Analysis
Traditionally, organizations such as Artivion use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Artivion within its industry.Artivion Manpower Efficiency
Return on Artivion Manpower
Revenue Per Employee | 236K | |
Revenue Per Executive | 13.1M | |
Net Loss Per Employee | 20.5K | |
Net Loss Per Executive | 1.1M | |
Working Capital Per Employee | 148.5K | |
Working Capital Per Executive | 8.3M |
Additional Tools for Artivion Stock Analysis
When running Artivion's price analysis, check to measure Artivion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artivion is operating at the current time. Most of Artivion's value examination focuses on studying past and present price action to predict the probability of Artivion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artivion's price. Additionally, you may evaluate how the addition of Artivion to your portfolios can decrease your overall portfolio volatility.